Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 296 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 946. Clear
Clear
Q2
EMD SERONO, INC. for EMD SERONO INC
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Trade (domestic/foreign), Health Issues, Medicare/Medicaid
View →
Q2
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $70,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Medical/Disease Research/Clinical Labs
View →
Q2
BIOGEN for BIOGEN
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View →
Q2
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) for AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Insurance, Pharmacy
View →
Q2
TODD STRATEGY GROUP for ALNYLAM PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q2
JAZZ PHARMACEUTICALS, INC. for JAZZ PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Pharmacy
View →
Q2
JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate
Defense, Health Issues, Budget/Appropriations, Copyright/Patent/Trademark
View →
Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q2
W STRATEGIES, LLC for INCYTE CORPORATION
2nd Quarter (Apr 1 - June 30) 2026 · Delaware · House · $60,000.00 income
Medicare/Medicaid
View →
Q2
W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · $40,000.00 income
Medicare/Medicaid
View →
Q2
W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP
2nd Quarter (Apr 1 - June 30) 2026 · Delaware · House · Senate · $80,000.00 income
Medicare/Medicaid
View →
Q2
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Animals
View →
Q2
AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · $50,000.00 income
Health Issues, Medicare/Medicaid
View →
Q2
INCYTE CORPORATION for INCYTE CORPORATION
2nd Quarter (Apr 1 - June 30) 2026 · Delaware · House · Senate
Medicare/Medicaid
View →
Q2
NOVARTIS for NOVARTIS
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q2
TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Medicare/Medicaid, Health Issues, Trade (domestic/foreign)
View →
Q2
ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
2nd Quarter (Apr 1 - June 30) 2026 · Delaware · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark
View →
Q2
CHRONIC CARE POLICY ALLIANCE for CHRONIC CARE POLICY ALLIANCE
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Health Issues
View →
Q2
NEUROCRINE BIOSCIENCES, INC for NEUROCRINE BIOSCIENCES, INC
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Medicare/Medicaid, Health Issues, Budget/Appropriations, Taxation/Internal Revenue Code
View →
Q2
ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)
View →
Q2
PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q2
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q2
DAIICHI SANKYO, INC. for DAIICHI SANKYO INC
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Health Issues, Taxation/Internal Revenue Code, Medicare/Medicaid, Copyright/Patent/Trademark
View →
Q2
TIBER CREEK GROUP for ALNYLAM PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q2
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Page 1 of 12 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem